Reproductive performance and embriotoxicity of rats exposed to carbamazepine

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 3, 2008, Pages 509-514

  Gerenutti, Marli ^a   De Oliveira, Carolina Clavijos ^a   De Miranda, Aliana Conceição Ribeiro ^a   Rosa, Raquel Mendonça ^a   Del Fiol, Fernando De Sá ^a  

^a UNIVERSITY OF SOROCABA   (Brazil)

Author keywords

Carbamazepine; Embriotoxicity; Pregnancy; Reproduction; Teratology

Indexed keywords

CARBAMAZEPINE; PROPYLENE GLYCOL;

ANIMAL TISSUE; ARTICLE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; EMBRYO; EMBRYOTOXICITY; FEMALE; FEMUR; FETUS; FETUS DEVELOPMENT; HIP; MALE; NEWBORN; NONHUMAN; OSSIFICATION; PRENATAL DRUG EXPOSURE; RAT; REPRODUCTIVE TOXICITY; SKULL DEVELOPMENT; STERNUM; WEIGHT GAIN;

EID: 55849153520     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000300022     Document Type: Article

References (29)

1. ADAB, N.; JACOBY, A.; SMITH D.; CHADWICK, D. Neurosurgery and Psychiatry. J. Neurol., v.70, n. 1, p.15, 2001.
2. AZARBAYJANI, F.; DANIELSSON. B.R. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs? Teratology, v. 57, n.3, p.117-126,1998.
3. BARROW, M.V. TAYLOR, W.J. A rapid method for detecting malformations in rat fetuses. J. Morphol., v.127, n.3, p.291-306, 1969.
4. BAUER, J.;HERMANN, A.; REUBER, M. Tolerance of high dosage carbamazepine monotherapy in treatment of epilepsy. Nervenarzt, v.73, n.6, p.533-537, 2002.
5. BOURGEOIS, B.F. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology, v.55, n.11 (suppl. 3), s.11-16, 2000.
6. CANGER, R.; BATTINO, D.; CANAVINI, M.P.; FUMAROLA, C.; GUIDOLIN, L.; VIGNOLI, A.; MAMOLI D. Malformations in offspring of women with epilepsy: a prospective study. N. Eng. J. Med., v.344, n.15, p.1132-8, 2001.
7. CHRISTENSEN, H.D.; RAYBURN, W.F.; PARKER, K.M.; GONZALEZ, C.L.; GOLD, K.P. Chronic prenatal exposure to carbamazepine and perinatal outcomes of C3H/He mice. Am. J. Obstet. Gynecol., v.190, n.2, p.517-21, 2004.
8. DAWSON, A.B. Note on the staining of skeleton of cleared skeletal specimens with alizarin red S. Stain. Technology, v.1, p.123-124, 1926.
9. DEL FIOL, F.; GERENUTTI, M.; GROPPO, F.C. Antibiotics and pregnancy. Pharmazie, v.60, n.7, p.483-493, 2005.
10. GAILY E, KANTOLA-SORSA E, HIILESMAA V, ISOAHO M, MATILA R, KOTILA M. Normal intelligence in children with prenatal exposure to carbamazepine. Zentralbl Gynakol , v.1, n.18 (suppl. 3), p.169-171, 1996.
11. GERENUTTI, M.; DEL FIOL, F.; GROPPO, F.C. Reproductive performance of pregnant rats and embryotoxic effects of ciprofloxacin. Pharmazie, v.61, n.1, p.79-80, 2006.
12. GERENUTTI, M.; DE-SOUZA SPINOSA, H.; BERNARD, M.M. Algumas considerações sobre a toxicologia do desenvolvimento. Comunicações Científicas da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo, v.1, p.27-29, 1991.
13. IQBAL, M.M.; SOHHAN, T.; MAHMUD, S.Z. The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J. Toxicol. Clin. Toxicol., v.39, n.4, p.381-392, 2001.
14. JICK, S.S.; TERRIS, B.Z. Anticonvulsants and congenital malformations. Reprod. Toxicol.. v. 16, n.1, p.9-17, 2002.
15. KAAJA, E.; KAAJA, R.; HIILESMAA, V. Major malformations in offspring of women with epilepsy. Neurology, v.62, n.1, p.28-32, 2004.
16. KANEKO, S.; OTANI, K.; KONDO, T.; FUKUSHIMA, Y.; NAKAMURA, Y.; OGAWA, Y. et al. Malformation in infants of the mothers with epilepsy receiving antiepileptic drus. Neurology, v.57, n.2, p.321-324, 2001.
17. KATO, H.; MORISHIGE, W.K.; ROTCHILD, I. A quantitative relationship between the experimentally determined number of conceptuses and corpus luteus activity in pregnant rats. Endocrinology, v.105, n.3, p.846-850, 1979.
18. LEMONICA, I.P.; DAMASCENO, D.C.; DI-STASI, L.C. Study of the embryotoxic effects of an extract of rosemary (Rosmarinus officinalis L.). Braz. J. Med. Biol. Res., v.29, n.2, p.223-227, 1996.
19. MANSON, J.M.; KANG, Y.J. Test methods for assessing female reproductive and developmental toxicology. In: HAYES, A.W., (Eds.). Principles and methods of toxicology. New York: Raven Press, 1994. p. 989-1037.
20. MANTOVANI, A.; CALAMANDREI, G. Delayed developmental effects following prenatal exposure to drugs. Curr. Pharm. Des.,v.7, n.9, p.859-880, 2001.
21. MCCABE, P.H. New anti-epileptic drugs for the 21st century. Expert Opin. Pharmacother., v.1, n.4, p.633-674, 2000.
22. ORTIZ, M.E.; VILLALÓN, M.; CROXATTO, H.B. Ovum transport and fertility following post ovulatory treatment with estradiol in rats. Biol. Reprod., v. 21, n.5, p.1163-1167, 1979.
23. RAYBURN, W.F.; GONZALEZ, C.L.; PARKER, K.M.; CHRISTENSEN, H.D. Chronic prenatal exposure to carbamazepine and behavior effects on mice offspring. Neurotoxicol. Teratol., v.22, n.5, p.733-739, 2000.
24. SAMREN, E.B.; VAN DUIJN, C.M.; CHRISTIAENS, G.C.; HOFMAN, A.; LINDHOUT, D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Epilepsy Behav., v. 4, n.4, p.447-448, 2003.
25. STERZ, H.; LEHMANN, H. A critical comparison of the freehand razor-blade dessection method acoording to Wilson with an in-situ sectioning method for the rat fetuses. Teratog. Carcinog. Mutag., v. 5, n.5, p.347-354, 1985.
26. VICKERY, B.H.; BENNETT, J.P. Rats and mice. In: HAFEZ, E.S.E., (Ed.). Reproduction and beeding techniques for laboratory animals. Philadelphia: Lea and Febiger, 1970. p. 299-315.
27. WAYNFORTH, H.B. Changes in the volume of rat corpus luteum during pregnancy and after surgical interference with the uterus and placenta. Acta Endocrinol., v.66, p.296-302, 1971.
28. WHELESS, J.W.; VENKATARAMAN, V. New formulations of drugs in epilepsy. Expert Opin. Pharmacother., v.1, n.1, p.49-60,1999.
29. WILLIAMS, J.; PATSALOS, P.N.; MEI, Z.; SCHAPEL, G.; WILSON, J.F.; RICHENS, A. Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant impatient epileptic population. Ther. Drug Monit., v. 23, n.1, p.15-20, 2001.